铜诱导的神经退行性疾病和黄含量的纳米乳液的治疗潜力
Govind Hake1, Akshada Mhaske1, Rahul Shukla1
1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Near CRPF Base Camp, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow 226002, India.
Toxics
|February 25, 2025
概括
一种新的黄素纳米乳液 (CUR-NE) 有效地保护神经元免受铜毒性的影响,为威尔逊病等神经退行性疾病的当前治疗提供了更安全的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经元中的铜积累会导致氧化应激和神经元死亡,这是神经退行性疾病的核心原因.
- 现有的铜毒性治疗有严重的副作用,需要更安全的替代方案.
- 黄素显示出治疗潜力,但其生物可用性较差.
研究的目的:
- 开发和评估一种含有黄素的纳米乳液 (CUR-NE),以提高生物可用性和神经保护.
- 评估CUR-NE在体外和体内对铜诱导的神经毒性的疗效.
- 探索CUR-NE作为一种新的治疗策略,用于与铜有关的神经退行.
主要方法:
- 用于制备CUR-NE的自发乳化技术.
- 关于CUR-NE粒子大小,泽塔潜力和封装效率的描述.
- 在体外研究中使用SH-SY5Y神经母细胞瘤细胞检测毒性和细胞吸收.
- 铜过载模型中的药理动力学和药理动力学评估.
主要成果:
- 优化的CUR-NE显示颗粒大小为76.42nm,泽塔电位为-20.4mV,封装效率为93.69%.
- CUR-NE对铜诱导的神经毒性和增强细胞吸收产生了显著的保护.
- 药理动力学研究表明,与自由黄素相比,CUR-NE的半衰期和循环时间更长.
- 药理动力学评估证实了CUR-NE在铜过载条件下提供卓越的神经保护.
结论:
- 含有黄素的纳米乳液 (CUR-NE) 有效地提高了黄素的生物可用性和治疗疗效.
- CUR-NE提出了一种有希望的,更安全的治疗方法来管理铜诱导的神经退行症.
- 纳米乳液输送平台可以显著改善神经系统疾病的化疗法.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
94
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
94
Alzheimer's Disease: Treatment
147
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
147


